Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 CAD | 0.00% | +0.27% | +23.93% |
Feb. 28 | Global Healthcare Leader Selects Kneat | CI |
Feb. 23 | Kneat.com Maintained at Buy at Stifel GMP After Q4 Results; Price Target Raised to C$4.15 | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 164.7 | 190.1 | 304.5 | 207.1 | 238.7 | 322.8 | - | - |
Enterprise Value (EV) 1 | 162 | 181.7 | 290.8 | 201.9 | 251.6 | 328.8 | 332.7 | 343.4 |
P/E ratio | -24.9 x | -31.3 x | -30.5 x | -22.3 x | -16.9 x | -22.7 x | -26.1 x | 378 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 41.7 x | 25.6 x | 19.6 x | 8.72 x | 6.97 x | 6.86 x | 5.11 x | 3.65 x |
EV / Revenue | 41 x | 24.5 x | 18.8 x | 8.5 x | 7.35 x | 6.99 x | 5.27 x | 3.88 x |
EV / EBITDA | -53 x | -52.1 x | -263 x | -68.8 x | -77.1 x | 128 x | 35.4 x | 27.5 x |
EV / FCF | -59.2 x | - | - | -22.6 x | -173 x | -22.1 x | -36.7 x | -69.4 x |
FCF Yield | -1.69% | - | - | -4.42% | -0.58% | -4.51% | -2.72% | -1.44% |
Price to Book | - | - | - | 7.98 x | 16.1 x | 10.2 x | 10.8 x | 8.59 x |
Nbr of stocks (in thousands) | 60,119 | 67,417 | 76,899 | 77,568 | 78,265 | 85,403 | - | - |
Reference price 2 | 2.740 | 2.820 | 3.960 | 2.670 | 3.050 | 3.780 | 3.780 | 3.780 |
Announcement Date | 4/22/20 | 2/23/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.95 | 7.422 | 15.5 | 23.75 | 34.22 | 47.06 | 63.19 | 88.55 |
EBITDA 1 | -3.057 | -3.487 | -1.106 | -2.936 | -3.265 | 2.566 | 9.411 | 12.5 |
EBIT 1 | - | - | - | -9.774 | -13.53 | -14.86 | -16.36 | - |
Operating Margin | - | - | - | -41.16% | -39.55% | -31.57% | -25.88% | - |
Earnings before Tax (EBT) 1 | -6.197 | - | -9.838 | -9.132 | -14.06 | -15.85 | -15.39 | - |
Net income 1 | -6.197 | -5.691 | -9.859 | -9.148 | -14.12 | -15.03 | -15.39 | - |
Net margin | -156.88% | -76.68% | -63.6% | -38.52% | -41.26% | -31.94% | -24.36% | - |
EPS 2 | -0.1100 | -0.0900 | -0.1300 | -0.1200 | -0.1800 | -0.1667 | -0.1450 | 0.0100 |
Free Cash Flow 1 | -2.738 | - | - | -8.918 | -1.457 | -14.84 | -9.058 | -4.95 |
FCF margin | -69.31% | - | - | -37.55% | -4.26% | -31.54% | -14.33% | -5.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 4/22/20 | 2/23/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.734 | 6.263 | 5.2 | 5.548 | 5.752 | 7.25 | 7.965 | 8.039 | 8.405 | 9.814 | 10.56 | 11.26 | 11.94 | 13.31 | 14 |
EBITDA 1 | -2.222 | 1.099 | -0.0643 | -0.7039 | -0.8896 | -1.281 | -1.094 | -1.281 | -0.5361 | - | -0.0804 | 0.1508 | 1.027 | 1.384 | 2.8 |
EBIT 1 | - | - | - | - | -2.527 | -3.281 | -3.351 | -3.944 | -3.177 | -3.062 | -3.516 | -3.664 | -3.712 | -3.966 | - |
Operating Margin | - | - | - | - | -43.94% | -45.25% | -42.07% | -49.06% | -37.8% | -31.2% | -33.31% | -32.53% | -31.09% | -29.8% | - |
Earnings before Tax (EBT) 1 | -2.51 | -1.529 | -3.426 | -3.634 | -2.547 | 0.4755 | -2.466 | -5.399 | -3.591 | -2.607 | -3.82 | -4.06 | -3.884 | -4.086 | - |
Net income 1 | -2.51 | -1.55 | -3.426 | -3.634 | -2.547 | 0.4589 | -2.474 | -5.399 | -3.591 | -2.655 | -3.78 | -3.973 | -3.59 | -3.691 | - |
Net margin | -67.21% | -24.74% | -65.89% | -65.5% | -44.28% | 6.33% | -31.07% | -67.15% | -42.73% | -27.05% | -35.8% | -35.27% | -30.07% | -27.73% | - |
EPS 2 | -0.0300 | -0.0200 | -0.0400 | -0.0500 | -0.0300 | 0.0100 | -0.0300 | -0.0700 | -0.0500 | -0.0300 | -0.0433 | -0.0467 | -0.0400 | -0.0333 | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/9/21 | 2/23/22 | 5/11/22 | 8/10/22 | 11/9/22 | 2/22/23 | 5/9/23 | 8/8/23 | 11/8/23 | 2/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 12.9 | 5.94 | 9.91 | 20.6 |
Net Cash position 1 | 2.74 | 8.38 | 13.7 | 5.19 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -3.956 x | 2.314 x | 1.053 x | 1.648 x |
Free Cash Flow 1 | -2.74 | - | - | -8.92 | -1.46 | -14.8 | -9.06 | -4.95 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | 0.3300 | 0.1900 | 0.3700 | 0.3500 | 0.4400 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | 0.5 | 0.65 | 0.33 | 0.18 | 0.5 | - | - |
Capex / Sales | - | 6.78% | 4.17% | 1.4% | 0.53% | 1.06% | - | - |
Announcement Date | 4/22/20 | 2/23/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.93% | 236M | |
+11.17% | 322B | |
+24.75% | 216B | |
+2.41% | 149B | |
+10.65% | 56.27B | |
+8.71% | 32.13B | |
-4.57% | 27.45B | |
+103.03% | 22.62B | |
+20.22% | 19.55B | |
+13.06% | 14.69B |
- Stock Market
- Equities
- KSI Stock
- Financials kneat.com, inc.